Injex Pharma Overview
- Founded
-
2006
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Injex Pharma General Information
Description
Manufactures of intradermal and subcutaneous needle injection applications designed to offer needle-free syringes. The company's intradermal and subcutaneous needle injections are used for dental, homeosiniatry, diabetes, anaesthesia and dupuytren pupose enabling the medical industry avail a range of needle injection applications for medical and cosmetic transdermal therapies.
Contact Information
Website
www.injex.de
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Parent Company
Hangzhou Hema Medical Equipment
Primary Office
- Buckower Damm 114
- 12349 Berlin
- Germany
Injex Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Injex Pharma Patents
Injex Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-D940302-S1 | Needleless injector | Active | 20-Jan-2020 | 0 |
Injex Pharma Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Thomas Klaue | Geschaftsfuhrer and Chairman | ||
| Jim Fukushima | Chief Executive Officer |
Injex Pharma Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000000 00000 | Injex Pharma | Geschaftsfuhrer and Chairman | 000 0000 |
Injex Pharma Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|